Device Trial Radar · NCT02343003
Nerve Ablation by Cooled Radiofrequency Compared to Corticosteroid Injection for Management of Knee Pain
Last checked: Nov 21, 2026Latest source record: May 13, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
151
Actual
Start
Jan 2015
Primary completion
Aug 2016
Study completion Mar 16, 2017
Sponsor
- Lead sponsor
- Halyard HealthNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 21, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to: * Determine the effectiveness (primarily measured by pain relief) of Coolief when used to create radiofrequency lesions of the genicular nerves compared to pain relief following corticosteroid injection; and * Confirm the safety of Coolief when used to perform radiofrequency lesions of the genicular nerves in subjects to manage knee pain compared to safety of corticosteroid injection
Conditions
- Osteoarthritis of the Knee
Interventions
Cooled RadiofrequencyDevice
Delivery of energy to ablate sensory nerves via cooled radiofrequency probe
Corticosteroid injectionDrug
Delivery of corticosteroid into knee by injection with needle to reduce knee pain
Primary outcomes
What the sponsor says the trial is designed to measure.
- Numeric Rating Scale (NRS)Time frame: 6 months
1 more outcomes with a free account
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
Valley Anesthesiology Consultants - Estrella
Phoenix, Arizona
10 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.